- Home
- ACLX vs AMG Comparison
ACLX vs AMG Comparison
Compare ACLX & AMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLX
- AMG
- Stock Information
- Founded
- ACLX 2015
- AMG 1993
- Country
- ACLX United States
- AMG United States
- Employees
- ACLX N/A
- AMG N/A
- Industry
- ACLX Biotechnology: Pharmaceutical Preparations
- AMG Investment Managers
- Sector
- ACLX Health Care
- AMG Finance
- Exchange
- ACLX Nasdaq
- AMG Nasdaq
- Market Cap
- ACLX 4.1B
- AMG 6.6B
- IPO Year
- ACLX 2022
- AMG 1997
- Fundamental
- Price
- ACLX $76.19
- AMG $235.94
- Analyst Decision
- ACLX Strong Buy
- AMG Strong Buy
- Analyst Count
- ACLX 13
- AMG 5
- Target Price
- ACLX $114.75
- AMG $250.80
- AVG Volume (30 Days)
- ACLX 551.2K
- AMG 180.7K
- Earning Date
- ACLX 11-06-2025
- AMG 11-03-2025
- Dividend Yield
- ACLX N/A
- AMG 0.02%
- EPS Growth
- ACLX N/A
- AMG N/A
- EPS
- ACLX N/A
- AMG 13.84
- Revenue
- ACLX $56,979,000.00
- AMG $2,030,400,000.00
- Revenue This Year
- ACLX N/A
- AMG $3.04
- Revenue Next Year
- ACLX $174.18
- AMG $9.32
- P/E Ratio
- ACLX N/A
- AMG $17.06
- Revenue Growth
- ACLX N/A
- AMG 0.11
- 52 Week Low
- ACLX $47.86
- AMG $139.22
- 52 Week High
- ACLX $107.37
- AMG $238.29
- Technical
- Relative Strength Index (RSI)
- ACLX 63.27
- AMG 71.40
- Support Level
- ACLX $70.11
- AMG $228.53
- Resistance Level
- ACLX $73.10
- AMG $235.00
- Average True Range (ATR)
- ACLX 2.57
- AMG 4.19
- MACD
- ACLX 0.55
- AMG 0.20
- Stochastic Oscillator
- ACLX 79.16
- AMG 84.88
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
About AMG Affiliated Managers Group Inc.
Affiliated Managers Group offers investment strategies to investors through its network of affiliates. The firm typically buys a majority interest in small to mid-size boutique asset managers, receiving a fixed percentage of revenue from these firms in return. Affiliates operate independently, with AMG providing strategic, operational, and technology support, as well as global distribution. At the end of March 2025, AMG's affiliate network—which includes firms like Abacus Capital and Pantheon dedicated to private markets (which accounted for 20% of AUM), AQR Capital and Capula Investment Management in liquid alternatives (22%), and Harding Loevner, Tweedy Browne, Parnassus, and Yacktman in equities, multi-asset, and bond strategies (58%)—had $712 billion in managed assets.